
David H Bechhofer, PhD
About Me
Dr. Bechhofer received his undergraduate degree in Biochemistry from City College of New York (CUNY) in 1978. His thesis research as a graduate student at Columbia University, Department of Microbiology, focused on maintenance of the broad-host-range plasmid, RK2. After receiving a Ph.D. degree from Columbia in 1984, Dr. Bechhofer went on to postdoctoral studies in the laboratory of Dr. David Dubnau at the Public Health Research Institute of New York, where he was introduced to the subject that remains the focus of his research efforts: regulation of mRNA stability in Bacillus subtilis. Dr. Bechhofer joined Mount Sinai as an Assistant Professor in 1986. Research in his laboratory has been funded by the NIH since 1987. He was appointed Associate Professor in 1993, and Professor in 2008 jointly in the Department of Pharmacology and Systems Therapeutics and the Department of Medical Education. Since 2001, Dr. Bechhofer has been director of the first-year medical school “Molecules and Cells” course, which covers basic biochemistry, cell and molecular biology, electrophysiology, and metabolism.
Language
English
Position
PROFESSOR | Pharmacological Sciences, PROFESSOR | Medical Education
Education
MS, Columbia University
PhD, Columbia University
Postdoctoral Fellowship, Public Health Research Institute of New York
Awards
2007
NIH Microbial Genetics Study Section
2004
NIH Microbial Genetics Study Section
1993
NIH Microbial Genetics Study Section
1984
USPHS Postdoctoral Fellowship Award (GM09853)
1978
USPHS Predoctoral Training Grant (AI07161)
1978
Max Pavey Award for Excellence in Chemistry
Research
Specific Clinical/Research Interests:
Prokaryotic mRNA decay and stable RNA processing
Postdoctoral Fellows: Gintaras Deikus, Shiyi Yao
Summary of Research Studies:
Several genes encoding ribonucleases have been cloned, including four genes encoding 3’-to-5’ exonucleases and one gene encoding a narrow-specificity endonuclease (called “Bs-RNase III”). In order to understand the function of these exonucleases, we are analyzing decay of endogenous mRNAs in mutant strains lacking one or more of these genes. We are concentrating on small, monocistronic mRNAs, as these are amenable to detailed analysis and likely provide few sites for initiation of decay.
Recent progress in the study of mRNA decay in B. subtilis has led to the discovery of a new class of ribonucleases, called RNase J. Amazingly, enzymes in this class have both endonucleolytic and 5’ exonucleolytic activities. B. subtilis has two RNase J enzymes, RNase J1 and J2, and RNase J1 is essential. We have found that the 5’ exonuclease activity of RNase J1 is sensitive to the phosphorylation state of the 5’ end; RNase J1 degrades an mRNA with a 5’-monophosphate end but not an mRNA with a 5’-triphosphate end. Based on the characteristics of RNase J1, a model for mRNA turnover in B. subtilis, which differs from the accepted model in E. coli, has been developed. Ongoing in vitro and in vivo studies are aimed at understanding the role of RNase J1 in global mRNA decay. The 140-nucleotide trp leader RNA has proved to be a valuable model, and our studies have allowed us to describe in complete detail the turnover of this RNA. In 2009, another essential endonuclease has been discovered in B. subtilis, named RNase Y. We have recently published the first report of a specific messenger RNA whose stability is determined by RNase Y.
Collaborations with other laboratories are in progress on the following projects:
- The effect of polyadenylation on mRNA decay. We have demonstrated that B. subtilis mRNA is polyadenylated, but the identity of the B. subtilis poly(A) polymerase has been a mystery. Biochemical purification of a poly(A) polymerase activity is anticipated, which will be followed by genetic studies of a strain lacking this activity.
- Removal of the inhibiting 5’-triphosphate end. It has been demonstrated in E. coli that removal of a pyrophosphate group to give a monophosphate 5’ end can be an important step in the initiation of mRNA decay. Based on genome homology predictions, B. subtilis contains at least six putative pyrophosphohydrolase genes, and these are being evaluated for their role in mRNA decay.
- In vitro activity of RNase J1. Numerous RNAs synthesized in vitro are being used to examine the properties of RNase J1. With the appropriate conditions, these test RNAs can be labeled at their 5’ end, their 3’ end, or internally, and analysis of the products of digestion of these RNAs with RNase J1 will be helpful in revealing how RNase J1 binds to and cleaves its target RNAs.
For more information, please visit the Bechhofer Laboratory website.
Publications
Selected Publications
- Structural insights into RNA cleavage by a novel family of bacterial RNases. Ruoxi Wu, Shakti Ingle, Sarah A. Barnes, Heather R. Dahlin, Susmita Khamrui, Yufei Xiang, Yi Shi, David H. Bechhofer, Michael B. Lazarus. Nucleic Acids Research
- Bacillus subtilis NrnB is expressed during sporulation and acts as a unique 3'-5' exonuclease. Tanner M. Myers, Shakti Ingle, Cordelia A. Weiss, Holger Sondermann, Vincent T. Lee, David H. Bechhofer, Wade C. Winkler. Nucleic Acids Research
- Analysis of mRNA Decay Intermediates in Bacillus subtilis 3' Exoribonuclease and RNA Helicase Mutant Strains. Shivani Chhabra, Zachary F. Mandell, Bo Liu, Paul Babitzke, David H. Bechhofer. mBio